Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Hartmann

Showing results (261-270 of 472) with videos related to

Pageof 48
Sort By:
British Journal of Cancer|August 17, 2000
A phase II study of paclitaxel, weekly, 24-hour continous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancerC Kollmannsberger, D Quietzsch, C Haag, et al.
Molecular Medicine (Cambridge, Mass.)|August 19, 2000
Quantification of Alzheimer amyloid beta peptides ending at residues 40 and 42 by novel ELISA systemsM Jensen, T Hartmann, B Engvall, et al.
Lung Cancer (Amsterdam, Netherlands)|December 7, 2007
Phase II study of plitidepsin in pretreated patients with locally advanced or metastatic non-small cell lung cancerChristian Peschel, Joerg T Hartmann, Alexander Schmittel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2009
Pharmacogenetic analyses of a phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil and leucovorin plus either oxaliplatin or cisplatin: a study of the arbeitsgemeinschaft internistische onkologieEray Goekkurt, Salah-Eddin Al-Batran, Jörg T Hartmann, et al.
Anti-Cancer Drugs|June 5, 2002
Phase II study of weekly paclitaxel plus 24-h continuous infusion 5-fluorouracil, folinic acid and 3-weekly cisplatin for the treatment of patients with advanced gastric cancerF Honecker, C Kollmannsberger, D Quietzsch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2010
PET/CT with 18F-FLT: does it improve the therapeutic management of metastatic germ cell tumors?Christina Pfannenberg, Philip Aschoff, Helmut Dittmann, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|June 9, 2014
Separation anxiety disorder in adult patients with obsessive-compulsive disorder: prevalence and clinical correlatesA P Franz, L Rateke, T Hartmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
First-line high-dose chemotherapy compared with standard-dose PEB/VIP chemotherapy in patients with advanced germ cell tumors: A multivariate and matched-pair analysisC Bokemeyer, C Kollmannsberger, C Meisner, et al.
The Journal of Biological Chemistry|May 31, 1996
Alzheimer's disease betaA4 protein release and amyloid precursor protein sorting are regulated by alternative splicingT Hartmann, C Bergsdorf, R Sandbrink, et al.
Oncology Reports|April 22, 2008
PTEN and p27Kip1 are not downregulated in the majority of renal cell carcinomas--implications for Akt activationJoerg Hennenlotter, Petra A Ohneseit, Perikles Simon, et al.
Pageof 48

Showing results (261-270 of 472) with videos related to

Sort By:
Pageof 48
British Journal of Cancer|August 17, 2000
A phase II study of paclitaxel, weekly, 24-hour continous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancerC Kollmannsberger, D Quietzsch, C Haag, et al.
Molecular Medicine (Cambridge, Mass.)|August 19, 2000
Quantification of Alzheimer amyloid beta peptides ending at residues 40 and 42 by novel ELISA systemsM Jensen, T Hartmann, B Engvall, et al.
Lung Cancer (Amsterdam, Netherlands)|December 7, 2007
Phase II study of plitidepsin in pretreated patients with locally advanced or metastatic non-small cell lung cancerChristian Peschel, Joerg T Hartmann, Alexander Schmittel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2009
Pharmacogenetic analyses of a phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil and leucovorin plus either oxaliplatin or cisplatin: a study of the arbeitsgemeinschaft internistische onkologieEray Goekkurt, Salah-Eddin Al-Batran, Jörg T Hartmann, et al.
Anti-Cancer Drugs|June 5, 2002
Phase II study of weekly paclitaxel plus 24-h continuous infusion 5-fluorouracil, folinic acid and 3-weekly cisplatin for the treatment of patients with advanced gastric cancerF Honecker, C Kollmannsberger, D Quietzsch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2010
PET/CT with 18F-FLT: does it improve the therapeutic management of metastatic germ cell tumors?Christina Pfannenberg, Philip Aschoff, Helmut Dittmann, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|June 9, 2014
Separation anxiety disorder in adult patients with obsessive-compulsive disorder: prevalence and clinical correlatesA P Franz, L Rateke, T Hartmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
First-line high-dose chemotherapy compared with standard-dose PEB/VIP chemotherapy in patients with advanced germ cell tumors: A multivariate and matched-pair analysisC Bokemeyer, C Kollmannsberger, C Meisner, et al.
The Journal of Biological Chemistry|May 31, 1996
Alzheimer's disease betaA4 protein release and amyloid precursor protein sorting are regulated by alternative splicingT Hartmann, C Bergsdorf, R Sandbrink, et al.
Oncology Reports|April 22, 2008
PTEN and p27Kip1 are not downregulated in the majority of renal cell carcinomas--implications for Akt activationJoerg Hennenlotter, Petra A Ohneseit, Perikles Simon, et al.
Pageof 48